Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1218 per EA under NDC 10702025350. Its NADAC has been published 377 times since Apr 10, 2019.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
Butalbital, Acetaminophen and CaffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
KVK-Tech Inc.NDC
10702025350
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA211106On Market Since
9/26/2018
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has been published 377 times since Apr 10, 2019, and over the history we have for it it has declined 57.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1218 per EA |
|---|---|
| All-time high | $0.2986 (Jul 10, 2019) |
| All-time low | $0.1112 (Nov 20, 2024) |
| 52-week high | $0.1493 |
| 52-week low | $0.1218 |
| Median price | $0.1675 |
| Average price | $0.1779 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 377 |
| Tracking since | Apr 10, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, manufactured by KVK-Tech Inc., is $0.1218 per EA (NDC 10702025350), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has declined 57.8%. It has been tracked across 377 weekly CMS publications since Apr 10, 2019.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
Since Apr 10, 2019, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has ranged from a low of $0.1112 (Nov 20, 2024) to a high of $0.2986 (Jul 10, 2019), with a median of $0.1675 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET (NDC 10702025350) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification